SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HMSC- A simple breast cancer screening device

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FCC who wrote (200)5/8/1998 7:16:00 AM
From: Q.   of 246
 
All: the price spike > $12 in March was too much for one HMSC
director to resist. He sold in quite a few transactions. Below you
will find the the Form 4 he filed yesterday, followed by his
biography in the DEF14a proxy.

Form 4 for HUMASCAN INC filed on Apr 7 1998

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
Toledano, Udi

545 Madison Avenue, Suite 800
New York, NY 10022
USA
2. Issuer Name and Ticker or Trading Symbol
HumaScan Inc.
HMSC
3. IRS or Social Security Number of Reporting Person (Voluntary)

4. Statement for Month/Year
March 31, 1998
5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
(X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other
(specify below)

7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect |
| Transaction | or Disposed of (D) | Securities |ect | Beneficial Ownership |
| | | | Beneficially |(D)or | |
| | | | | A/| | Owned at |Indir | |
| Date |Code|V| Amount | D | Price | End of Month |ect(I)| |
___________________________________________________________________________________________________________________________________|
Common Stock |3/6/98|S | |3,500 |D |$12.00 per | |D | |
| | | | | |share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/3/98|S | |4,200 |D |$12.50 per | |D | |
| | | | | |share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/3/98|S | |1,500 |D |$12.125 per| |D | |
| | | | | | share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/3/98|S | |100 |D |$12.71875 p| |D | |
| | | | | |er share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/3/98|S | |5,000 |D |$12.75 per | |D | |
| | | | | |share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/3/98|S | |100 |D |$12.6875 pe| |D | |
| | | | | |r share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/3/98|S | |600 |D |$12.5625 pe| |D | |
| | | | | |r share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/9/98|S | |1,065 |D |$10.125 per| |I |(1) |
| | | | | | share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |3/10/9|S | |1,065 |D |$10.625 per| |I |(1) |
|8 | | | | | share | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |81,875 | | |
-----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con- |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of|
Security |version |Transaction | rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect |
|or Exer | | | rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial |
|cise | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership |
|Price of| | | posed of(D) |Day/Year) | |rity |Benefi |or | |
|Deriva- | | | |Date |Expir| | |ficially |Ind| |
|tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| |
|Secu- | | | | | D |cisa-|Date | of Shares | |End of |ct | |
|rity |Date |Code|V| Amount | |ble | | | |Month |(I)| |
___________________________________________________________________________________________________________________________________|
Warrants |$2.93 |3/6/9|C | |4,500 |D |(2) | |Common Stock|1,065 |$2.93 |0 |I |(1) |
| |8 | | | | | | | | | | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
Warrants |$2.93 |3/9/9|C | |4,500 |D |(2) | |Common Stock|1,065 |$2.93 |0 |I |(1) |
| |8 | | | | | | | | | | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | | | | | |
___________________________________________________________________________________________________________________________________|
Explanation of Responses:
(1) Securities owned by certain other members of the reporting person's
family. The reporting person discaims
beneficial ownership of these securities, and this report shall not be
deemed
an admission that the reporting person is the beneficial owner of such
securities for purposes of Section 16 or
for any other
purpose.
(2) Such warrants may be exercised for an aggregate of only 2,930 shares
because the Common Stock traded
publicly at a price per share of at least $7.33
more than six months but less than nine months from May 15,
1996.
SIGNATURE OF REPORTING PERSON
/s/ Udi Toledano
DATE
April 7, 1998

. Udi Toledano has been a director of the Company since May 1996. Mr.
Toledano has been the President of Andromeda Enterprises, Inc., a private
investment company, since December 1993. Prior to that, he was the President of
CR Capital Inc., a private investment company, for more than five years. He has
also been an advisor to various public and private corporations, none of which
is affiliated with or competes with the Company. Mr. Toledano is a director and
Chairman of the Board of Alyn Corporation, a producer of advanced materials, and
is a director of Global Pharmaceutical Corporation, a generic pharmaceuticals
manufacturer; Universal Stainless &
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext